Dr. Joseph John
Author Profile
1
Publications
1
Years Active
3
Collaborators
9
Citations
Publications by Dr. Joseph John
1 publication found • Active 2025-2025
2025
1 publicationDapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction
with Dr.
Namitha Rachel Biji, Prof. Dr. S.K Mathew, Dr. Dhanu Josey
10/1/2025
ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
Author Statistics
Total Publications:1
Years Active:1
First Publication:2025
Latest Publication:2025
Collaborators:3
Citations:9